Pharmacokinetics of antiretrovirals administered to HIV-infected children via gastrostomy tube

HIV Clinical Trials

Volumn 5, Issue 5, 2004, Pages 288-293

  King, Jennifer R ^a   Yogev, Ram ^b   Aldrovandi, Grace ^c   Chadwick, Ellen ^b   Acosta, Edward P ^a  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^b CHILDREN'S MEMORIAL HOSPITAL   (United States)

^c CHILDREN S HOSPITAL LOS ANGELES   (United States)

Author keywords

Antiretrovirals; Gastronomy tube; Pharmacokinetics

Indexed keywords

ABACAVIR; AMPRENAVIR; AMPRENAVIR PHOSPHATE; ANTIRETROVIRUS AGENT; DIDANOSINE; EFAVIRENZ; LAMIVUDINE; LOPINAVIR; NELFINAVIR; PROTEINASE INHIBITOR; RITONAVIR; RNA DIRECTED DNA POLYMERASE INHIBITOR; SAQUINAVIR; STAVUDINE; TENOFOVIR; ZIDOVUDINE;

ARTICLE; BLOOD SAMPLING; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG ABSORPTION; DRUG BLOOD LEVEL; DRUG DISTRIBUTION; DRUG EXPOSURE; GASTROINTESTINAL TRACT; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; PATIENT COMPLIANCE; PILOT STUDY; PRIORITY JOURNAL; STOMACH TUBE; ULTRAVIOLET RADIATION;

AREA UNDER CURVE; CHILD; CHILD WELFARE; CHILD, PRESCHOOL; FEMALE; GASTROSTOMY; HIV INFECTIONS; HUMANS; INTUBATION, GASTROINTESTINAL; MALE; PILOT PROJECTS; PROTEASE INHIBITORS; REVERSE TRANSCRIPTASE INHIBITORS;

EID: 9144261744     PISSN: 15284336     EISSN: None     Source Type: Journal    
DOI: 10.1310/GRQX-761M-DPB1-V9CG     Document Type: Article

References (13)

1. Shingadia D, Viani R, Rolando M, et al. Gastrostomy tube insertion for improvement of adherence to highly active antiretroviral therapy in pediatric patients with human immunodeficiency virus. Pediatrics. 2000;105(6):1326.
2. Healy DP, Brodbeck MC, Clendening CE. Ciprofloxacin absorption is impaired in patients given enteral feedings orally and via gastrostomy and jejunosotmy tubes. Antimicrob Agents Chemother. 1996;40(1):6-10.
3. Faraji B, Yu PP. Serum phenytoin levels of patients on gastrostomy tube feedings. J Neuroscience Nurs. 1998;30(1):55-59.
4. Acosta EP, Nachman S, Wiznia A, et al. Pharmacokinetic (PK) evaluation of nelfinavir (NFV) in combination with nevirapine (NVP) or ritonavir (RTV) in HIV-infected children - PACTG 403. In: 40th ICAAC Abstracts. Washington, DC: American Society for Microbiology; 2000. Abstract 1642.
5. Turner ML, Reed-Walker, K, King JR, et al. Simultaneous determination of nine antiretroviral compounds in human plasma using liquid chromatography. J Chromatogr B. 2003;784:331-341.
6. Gibaldi M, Perrier D. Pharmacokinetics, 2nd ed. New York, NY: Marcel Dekker; 1982.
7. Starr SE, Fletcher CV, Spector SA, et al. Combination therapy with efavirenz, nelfinavir, and nucleoside reverse-transcriptase inhibitors in children infected with human immunodeficiency virus type 1. Pediatric AIDS Clinical Trials Group 382 Team. N Engl J Med. 1999;341(25):1874-1881.
8. Brundage RC, Kline MW, Lindsey J, et al. Pharmacokinetics of saquinavir (SQV) with nelfinavir (NFV) or ritonavir (RTV) in HIV-infected children. In: Program and abstracts of the 8th Conference on Retroviruses and Opportunistic Infections; February 10-14, 2002; Boston, MA. Alexandria, VA: Foundation for Retrovirology and Human Health; 2002. Abstract 728.
9. Amprenavir (Agenerase) [package insert]. Research Triangle Park, NC: Glaxo Smith Kline; 1999.
10. Wire MB, Preston SL, Ballow C, et al. An assessment of plasma amprenavir (APV) pharmacokinetics (PK) following administration of two GW433908 (908) and ritonavir (RTV) QD regimens in combination with efavirenz (EFV) in healthy adult subjects (APV10009). In: 41st ICAAC Abstracts. Washington, DC: American Society for Microbiology; 2001. Abstract 1737.
11. Lopinavir/ritonavir (Kaletra) [package insert]. North Chicago, IL: Abbott Laboratories; 2000.
12. Meynard JL, Poirer JM, Guiard-Schmid JB, et al. Impact of ABT 378/r on the amprenavir plasma concentrations in HIV-experienced patients treated by the association APV-ABT 378/r. In: 41st ICAAC Abstracts. Washington, DC: American Society for Microbiology; September, 2003. Abstract I-1736.
13. Taburet AM, Piketty C, Chazallon C, et al. Interactions between atazanavir-ritonavir and tenofovir in heavily pretreated human immunodeficiency virus-infected patients. Antimicrob Agents Chemother. 2004;48(6):2091-2096.